microsoft personalized ad preferences to opt out of personalized ads in this browser your browser history must allow firstparty and thirdparty cookies and you must have your browsing experience set to not delete browsing history on exit instructions for enabling cookies and configuring your browsing history may be available in your browsers settings privacy or help documentation sign in hold on… we’re sorry but this didn’t work you can’t turn off personalized ads right now because your browser is currently blocking thirdparty cookies we can help you fix this issue let’s get started depending on what browser you use open options or settings make sure that thirdparty cookies are not blocked anymore to find out how search your browser’s help revisit httpchoicemicrosoftcomoptout and then on the “personalized ads in this browser” tile click off ext about our ads to create a more customized online experience some of the ads you may receive on microsoft websites and apps are tailored to your previous activities searches and site visits youre in control and heres where you can make the advertising choice thats right for you ext where can i learn more about advertising on microsoft websites and apps microsoft partners with oath appnexus and other third party service providers to help present customized content and display advertisements on msn outlookcom and other websites and apps microsoft also delivers search ads to bing and our search syndication partners learn more about microsoft’s privacy practices here you can learn more about interestbased ads from oath and appnexus in their privacy statements oath and appnexus what choices do i have about interestbased advertising on this page you can opt out of receiving interest based advertising from microsoft you can also opt out of receiving interestbased advertising from all selfregulatory members including microsoft oath appnexus and other third party ad networks at the following sites in the us digital advertising alliance daa in europe european interactive digital advertising alliance edaa in canada ad choices digital advertising alliance of canada daac you can control interestbased advertising in windows apps by turning off the advertising id in windows settings more choices do you want personalized ads from other companies questions if you have a privacy question or a question for the chief privacy officer of microsoft please contact us by using our web form we will respond to questions within  days ext personalized ads in this browser off optout is currently unavailable please try again later control the personalized ads setting for this web browser learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off ext personalized ads wherever i use my microsoft account off sign in to change optout is currently unavailable please try again later control the personalized ads setting that applies when you are signed in on any computer or device with your microsoft account including windows windows phone xbox and other devices learn more if you want microsoft to show ads that might be relevant to you click on to show “generic” ads click off if you choose “generic” ads and use a browser your choice applies to everyone when using that browser as long as you do not clear your cookies ext personalized ads in windows in your windows settings you can turn off personalized ads that appear in apps on this device you’ll still see ads but they won’t be personalized anymore if you have windows  access the charms by touching or moving your pointer to the right edge of the screen click or tap settings and then click or tap change pc settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have windows  click or tap the start button click or tap settings click or tap privacy and then turn off let apps use my advertising id for experiences across apps if you have a windows mobile device go to settings tap on privacy tap on advertising id and then turn off let apps use my advertising id for experiences across apps if you want to turn off personalized ads from microsoft wherever you use your microsoft account including apps on windows windows phone xbox and other devices you can do so by selecting the microsoft account option above ext legal privacy  cookies   microsoft health advance inc signs letter of intent to acquire product formulations  marketwatch bulletin investor alert press release oct    am edt health advance inc signs letter of intent to acquire product formulations las vegas nv oct   marketwired via comtex  las vegas nvmarketwired  oct    health advance inc the company otc pinkhadv is pleased to announce it has entered into a nonbinding letter of intent to acquire certain proprietary product formulations for the manufacturer of generic drugs from patrick ocharchin a canadian resident the acquisition is subject to due diligence by health advance and the negotiation and execution of a definitive agreement the agreement will be subject to certain conditions including the company issuing shares of the company in exchange for the formulations held by mr ocharchin the company will analyze the value of the formulations and expects the due diligence period to last approximately  weeks the company believes the letter of intent is the next phase of its growth and development upon completion of the hantian transaction the company will utilize the strategic relationships formed by hantian to develop market and promote the formulations that will provide health advance with the greatest opportunities  the formulations are currently active in the following areas i central nervous system drugs such as anticonvulsants and antipsychotics ii antiinfection drugs such as erythromycin opthalmic ointment iii topical dermatology drugs such as topical antibiotics topical antifungals and antiinflammatories iv hormonal drugs such as steroidal drugs and v other drugs such as ophthalmics generic pharmaceuticals are bioequivalent same ingredients and therapeutic equivalent alternatives to brand name drugs that have lost the market exclusivity of patent protection generic drugs offer the same active chemical entity as trade name products but differ inert substance formulations inert ingredients include binders fillers artificial colors flavorings etc since these substances may affect the bioavailability performance of the active ingredient bioequivalence studies must be conducted by manufacturers and submitted to the federal food and drug administration fda before new generic products are approved for sale this file will show that the generic drug has the same ingredients in the same proportions as the brand product known as bioequivalence and performs the same as the brand product when taken known as bioavailability once this submission file is reviewed by fda and bioequivalence and bioavailability are confirmed an approval for sale is granted and the drug may be marketed all of the product formulations held by mr ocharchin have bioequivalence studies completed which will result in considerable time savings and cost savings certain statements in this document that are not historical facts are forwardlooking statements within the meaning of the private securities litigation reform act of  such statements may be identified by the use of words such as anticipate believe expect future may will would should plan projected intend and similar expressions such forwardlooking statements involve known and unknown risks uncertainties and other factors that may cause the actual results performance or achievements of health advance inc to be materially different from those expressed or implied by such forwardlooking statements the companys future operating results are dependent upon many factors including but not limited to i the companys ability to obtain sufficient capital or a strategic business arrangement to fund its current operational or expansion plans ii the companys ability to build and maintain the management and human resources and infrastructure necessary to support the anticipated growth of its business iii competitive factors and developments beyond the companys control and iv other risk factors discussed in the companys periodic filings with the securities and exchange commission which are available for review at wwwsecgov under search for company filings for more information please contact health advance inc jordan starkman ceo wwwhealthadvanceinccom  �  nasdaq inc all rights reserved most popular  market extra wall street isn’t ready for a point tumble in the dow industrials  all the companies in jeff bezos’s empire in one large chart  market snapshot sp  nasdaq finish lower after amazon disappointment dow closes at record  marketwatch first take intel earnings have message for amd and nvidia ‘bring it on’  sectorwatch silicon valleys corporatecampus building boom is a cautionary tale find a broker partner center » featured stories seeing america again through new eyes how to dig yourself out of debt move over tesla karma unveils its hybrid sports car the salary you need to afford a home in these  cities why opec will never cut production again log in  pm edt july   marketstatecountryus new york closed marketstatecountryuk london closed marketstatecountryjp tokyo closed marketstatecountryus   marketstatecountryuk   marketstatecountryjp   view all latest news newslatest pwall street isn’t ready for a point tumble in the dow industrials pbarrons buzz robo  facebook and twitter trading on news pa wild week in washington pthe dark side of cruises pthe highest paid athletes in the world in one chart poj simpson made over  while in prison and won’t have to give any of it to the goldman family p trump to police dont be too nice phere are  coworkers you should avoid like the plague — especially in meetings ptop  most annoying people you may want to unfriend on facebook pthis is one person you should never unfriend on facebook p horrible ways typos could alter the course of your life ppaint your bathroom this color and boost your home’s selling price by  pamericans’ new badge of honor ‘i was blocked by a celebrity’ p weird things i found out about america in my first  hours pbeyond tesla  stocks driving the autonomous car revolution pthese  highly taxed companies need congress to finally act on tax reform pwatch out ‘kids’ are making the most money in this stock market p real ways for millennials to save money not by brownbagging and skipping starbucks p‘game of thrones’ this computer model predicts who will be killed off — or survive pthis basic balanced index fund is beating the hedge fund averages loading more headlines dow quoteszigmanrealtime    nasdaq quoteszigmanrealtime    sp  quoteszigmanrealtime    kiosk   the retirementors retirement advice from our industry experts our team of financial professionals can help you plan and save for retirement then live well in it congakioskretirementorshtml    alerts congakioskalertshtml    virtual stock exchange our free stockmarket game • trade your virtual portfolio in real time • talk strategies in group discussions • find or create a game that suits you • use our learning center to improve congakioskgameshtml    location scouts housingmarket insights from our realty pros plus the latest data from realtorcom on  home markets across the us • see our complete real estate site congakioskrealestatehtml    lazy portfolios set it and forget it check out the returns on our  lazy portfolios that are made up of lowcost buyandhold index funds • how to create your own lazy portfolio congakiosklazyportfoliohtml  marketwatchcom site index topics help feedback newsroom roster media archive premium products mobile company info code of conduct corrections advertising media kit advertise locally reprints  licensing broker center your ad choices follow marketwatch rss podcasts wsjcom barrons online bigcharts virtual stock exchange financial news london wsjcom small business realtorcom mansion global copyright   marketwatch inc all rights reserved by using this site you agree to the terms of service privacy policy and cookie policy intraday data provided by six financial information and subject to terms of use historical and current endofday data provided by six financial information all quotes are in local exchange time realtime last sale data for us stock quotes reflect trades reported through nasdaq only intraday data delayed at least  minutes or per exchange requirements marketwatch top stories link to marketwatchs slice  advance health  about client login provider login homeaboutadvancing healthcareour providersadvanced technologyleadership teamnewssolutionsadvanced member managementadvanced solutionsreadmissions prevention programscare managementcontactcareersresources advancing healthcare advance health provides industry leading managed care prospective health solutions our combination of proprietary mobile workflow technology and highly experienced dedicated care providers yields outstanding program results and better outcomes for our clients and their health plan members we offer truly customized prospective member engagement solutions tailored for each of our clients unique needs advance health was created to leverage bestinclass technology for greater efficiency data security and automation we also want to bring better health care to managed care members by engaging them when and where they are most comfortable using the best available member specific information and workflow technology our providers one of the most important aspects of our member engagement programs is our nurse practitioners their professional support helps members feel more comfortable and find value in the programs designed to advance their care our model recognizes that importance and is unique in several ways first we collaborate with each plan to identify specific needs then we select nps who have the experience and expertise to meet those needs each np is client based and  of our network is local nps we believe this model best serves our clients and their members because the nps are part of the fabric of each community they know the area the providers and social services and can collaborate with them more efficiently than nonlocal providers who are typically outsourced and travel extensively we utilize a rigorous credentialing verification protocol to ensure the highest standards in care our nps are required to hold national certification aanpancc in family adult or geriatric care karen bolton rn ms fnpc texas years of experience tara lichtymorton iowa and nebraska years of experience karen lamberton tennessee years of experience marcia streiff kansas years of experience dana lynch  iowa and nebraska years of experience ryane riddle missouri years of experience amber riley indiana years of experience  ming chao        texas  years of experience samantha collinson missouri years of experience  advanced training our nps are trained managed and supported by fellow clinicians with many years of experience in fact our network of nps averages over nine years of experience caring for vulnerable populations and coordinating care in communitybased settings our rigorous program includes ongoing training and testing in cms compliant documentation customer service elder care clientspecific hra protocol and screeningdiagnostic procedures ryane riddle missouri  years of experience advanced technology advance health is leading the industry as the first company to completely capture assessments electronically through our proprietary ios ipad and html applications while others are still attempting to incorporate electronic capture or are in the infancy of their programs advance health has already moved on to the next generation our html application provides client level customization with builtin intelligence that triggers questions based on data input from a member’s response or exam results and provides customized recommendations and care plans specifically for that member in addition with our validate confirm delete technology nps are forced to address conditions identified during previous assessments and via claims data nps must verify the condition with documentation delete the condition as resolved or no longer present or provide detail required for network providers to followup to validate conditions our solution is the fastest in the industry providing submission coding and compliance for health plans and providers to help eliminate gaps in member engagement  care   the advance health technology advantage validate confirm delete technology client level customization fastest time for submission coding and compliance response triggered questions and care plans scheduling and call center sophistication to improve program results   our advanced technology solutions also extend throughout our scheduling and call center operations using the most sophisticated software we are able to maximize an np’s productivity without having to sacrifice quality this ensures more members are engaged to complete each plan’s goals leadership team the team at advance health has designed and implemented member engagement strategies for some of the country’s largest and most successful payers and risk management vendors in addition our board of directors provides sound guidance as early innovators in managed care serving at the helm of national health plans representing over b in revenues members of the advance health leadership team are active in the healthcare community promoting innovative ways to improve quality of care and dedicated to the long term success of our clients and the managed care industry brian j wise jd  chief executive officer brian wise is a seasoned managed care executive with extensive experience in government programs prior to founding advance health brian was the chief operating officer of amerigroup’s virginia health plan overseeing a m business unit  brian led provider relations product development compliance and appeals for coventry health care of nebraska successfully launching medicare advantage and commercial expansions during his tenure  he also served as inhouse counsel for coventry health care in the corporate headquarters brian served as an associate at epstein becker  green one of the preeminent health care law firms in the country and continues to advise health care investors and startups   mr wise received his jd from the university of virginia and undergraduate degrees in history and political science from duke universitymarc l wise  president marc wise has over  years of experience building business service organizations in the health care space before joining advance health marc served as senior vice president of business development at verisk health he came to verisk health as part of their acquisition of health risk partners a company focused on risk adjustment services and revenue optimization solutions in the medicare and medicaid markets during his five years with hrp marc helped grow revenues by more than  times  prior to hrp  verisk health marc served as chief operating officer for fedmed inc a provider of network whitespace outsourcing based in rockville md senior vice president for nco group inc a global business process outsource solutions company and dimark inc a preeminent health care and insurance direct marketing company marc holds a bachelor of business administration from delaware valley collegecatherine l wisner phd fnpbc  chief clinical officer cathy wisner is a certified family nurse practitioner with a phd in health services research policy and administration  she received her ms in nursing from vanderbilt university and her phd from the university of minnesota  prior to joining advance health dr wisner served as the chief of clinical operations for health right inc and director of quality management for amerigroup  cathy was formerly the senior health fellow in the office of the us surgeon general and served as vice president of operations and clinical quality for minuteclinic inc  helping it grow from a small regional company to a major division of cvscaremark with over  nps under management   dr wisner is well versed in healthcare policy and has authored several publications in peerreviewed journalskevin j kearns md  chief medical officer kevin kearns md is a board certified internist with a diverse background in medical management clinical practice managed care and academic medicine  prior to joining advance health dr kearns served as corporate vice president and senior medical director at universal american where he developed and implemented medical management strategies to enhance the healthy collaboration model for the medicare advantage membership previously dr kearns held senior positions at upmc health plan and coventry health care of delaware   dr kearns received his undergraduate degree in biology from st joseph university and completed medical school at the pennsylvania state university college of medicine dr kearns completed his internship in internal medicine at the university of maryland and his residency at thomas jefferson university hospitaldavid pierre  chief operating officer david pierre is an experienced healthcare and information technology executive responsible for complete delivery of advance health’s business operations prior to joining advance health in  david was vice president at cerner corporation responsible for pediatrics david cofounded and led the bear institute for health innovation in washington dc at children’s national the first pediatric healthcare technology institute in the world during his  years at cerner he led an increasing number of cerner’s business units including full pl responsibilities for the hospital operations unit he was responsible for launching five new solutions into the marketplace for cerner focused on optimizing efficiency for providers and improving quality of care in addition david acquired integrated and led clairvia a world leader of healthcare resource management solutions david holds a bachelor’s degree with honors in psychology from southern methodist university and an mba in finance and strategic management from the university of chicago booth school of businessalicia palmer  general counsel alicia palmer is a licensed attorney with more than  years of experience of providing legal counsel to health care companies prior to joining advance health ms palmer served as aetna’s vp and chief medicare counsel where she led a team of attorneys and legal professionals that were responsible for providing legal counsel to all of aetna’s medicare business prior to joining aetna ms palmer was a vice president and senior attorney at coventry health care inc for  years alicia served as an associate at crowell  moring and michaels  bonner and started her legal career as an associate general counsel for blue cross and blue shield of the national capital area in addition to her significant medicare advantage experience ms palmer has counseled clients throughout her twenty years of legal practice on various government programs pharmacy and pharmaceutical business and federal and state health care laws ms palmer received her bachelor of science degree in human resource management from indiana university of pennsylvania and her juris doctor degree from the american university washington college of lawmete sahin  chief financial officer mete sahin has an extensive career leading healthcare companies focusing on financial operations prior to advance health mr sahin was a consultant with acmm consulting llc beginning in  and prior to that he served as the cfo of xlhealth medicare advantage health plans from  through  during this period xlhealth grew from  million to  billion in revenues and demonstrated a significant turnaround in earnings xlhealth was acquired by unitedhealth group in  between  and  mr sahin was the cfo of unitedhealth groups dental and vision companies as well as cfo of its national medicaid health plans in his role he was a key executive directing the the reorganization of unitedhealths medicaid business and merger of its dental and vision companies prior to joining unitedhealth group through a merger mr sahin was the vp financecontroller of lifemark he earned his masters degree from university of surrey in england and bachelors degree from university of southern california in los angeles brian j wise jd  chief executive officer brian wise is a seasoned managed care executive with extensive experience in government programs prior to founding advance health brian was the chief operating officer of amerigroup’s virginia health plan overseeing a m business unit  brian led provider relations product development compliance and appeals for coventry health care of nebraska successfully launching medicare advantage and commercial expansions during his tenure  he also served as inhouse counsel for coventry health care in the corporate headquarters brian served as an associate at epstein becker  green one of the preeminent health care law firms in the country and continues to advise health care investors and startups   mr wise received his jd from the university of virginia and undergraduate degrees in history and political science from duke university marc l wise  president marc wise has over  years of experience building business service organizations in the health care space before joining advance health marc served as senior vice president of business development at verisk health he came to verisk health as part of their acquisition of health risk partners a company focused on risk adjustment services and revenue optimization solutions in the medicare and medicaid markets during his five years with hrp marc helped grow revenues by more than  times  prior to hrp  verisk health marc served as chief operating officer for fedmed inc a provider of network whitespace outsourcing based in rockville md senior vice president for nco group inc a global business process outsource solutions company and dimark inc a preeminent health care and insurance direct marketing company marc holds a bachelor of business administration from delaware valley college catherine l wisner phd fnpbc  chief clinical officer cathy wisner is a certified family nurse practitioner with a phd in health services research policy and administration  she received her ms in nursing from vanderbilt university and her phd from the university of minnesota  prior to joining advance health dr wisner served as the chief of clinical operations for health right inc and director of quality management for amerigroup  cathy was formerly the senior health fellow in the office of the us surgeon general and served as vice president of operations and clinical quality for minuteclinic inc  helping it grow from a small regional company to a major division of cvscaremark with over  nps under management   dr wisner is well versed in healthcare policy and has authored several publications in peerreviewed journals kevin j kearns md  chief medical officer kevin kearns md is a board certified internist with a diverse background in medical management clinical practice managed care and academic medicine  prior to joining advance health dr kearns served as corporate vice president and senior medical director at universal american where he developed and implemented medical management strategies to enhance the healthy collaboration model for the medicare advantage membership previously dr kearns held senior positions at upmc health plan and coventry health care of delaware   dr kearns received his undergraduate degree in biology from st joseph university and completed medical school at the pennsylvania state university college of medicine dr kearns completed his internship in internal medicine at the university of maryland and his residency at thomas jefferson university hospital mete j sahin  chief financial officer mete sahin has an extensive career leading healthcare companies focusing on financial operations prior to advance health mr sahin  was a consultant with acmm consulting llc beginning in  and prior to that he served as the  cfo of xlhealth medicare advantage health plans from  through  during this period xlhealth grew from  million to  billion in revenues and demonstrated a significant turnaround in earnings  xlhealth was acquired by unitedhealth group in  between  and  mr sahin was the cfo of unitedhealth groups dental and vision companies as well as cfo of its national medicaid health plans in his role he was a key executive directing the the reorganization of unitedhealths medicaid business and merger of its dental and vision companies prior to joining unitedhealth group through a merger  mr sahin was the vp financecontroller of lifemark he earned his masters degree from university of surrey in england and bachelors degree from university of southern california in los angeles alicia palmer  general counsel alicia palmer is a licensed attorney with more than  years of experience of providing legal counsel to health care companies  prior to joining advance health ms palmer served as aetna’s vp and chief medicare counsel where she led a team of attorneys and legal professionals that were responsible for providing legal counsel to all of aetna’s medicare business  prior to joining aetna ms palmer was a vice president and senior attorney at coventry health care inc for  years  alicia served as an associate at crowell  moring and michaels  bonner and started her legal career as an associate general counsel for blue cross and blue shield of the national capital area  in addition to her significant medicare advantage experience ms palmer has counseled clients throughout her twenty years of legal practice on various government programs pharmacy and pharmaceutical business and federal and state health care laws  ms palmer received her bachelor of science degree in human resource management from indiana university of pennsylvania and her juris doctor degree from the american university washington college of lawdavid pierre  chief operating officer david pierre is an experienced healthcare and information technology executive responsible for complete delivery of advance health’s business operations  prior to joining advance health in  david was vice president at cerner corporation responsible for pediatrics  david cofounded and led the bear institute for health innovation in washington dc at children’s national the first pediatric healthcare technology institute in the world  during his  years at cerner he led an increasing number of cerner’s business units including full pl responsibilities for the hospital operations unit  he was responsible for launching five new solutions into the marketplace for cerner focused on optimizing efficiency for providers and improving quality of care  in addition david acquired integrated and led clairvia a world leader of healthcare resource management solutions  david holds a bachelor’s degree with honors in psychology from southern methodist university and an mba in finance and strategic management from the university of chicago booth school of business compliance our solutions are built around compliance and all steps are taken to ensure publicly funded payors receive accurate compliant revenue advance health knows the vulnerabilities and utilizes enterprise management software to clock measure and report on our assessment activities we know the exact amount of time spent on each section of an assessment where it was performed and  of our assessments go through a rigorous quality assurance process the advantage of  electronic capture we know our assessments average  minutes because we can track time spent on every section our software tracks where each assessment takes place when time spent on an assessment section or the whole assessment falls below certain thresholds the assessment is flagged for additional follow up let us know how we can help we welcome your inquiries and look forward to supporting your care management quality improvement and riskbased reimbursement initiatives health advance inc signs letter of intent to acquire product formulations  newmediawire login contact us distributions distributions overview us news distributions international distribution custom industry packages targeted media  influencers photo distributions disclosureregulatory filings solutions solutions overview ir newsroom pr newsroom media database social media hub news center get started login contact us distributions distributions overview us news distributions international distribution custom industry packages targeted media  influencers photo distributions disclosureregulatory filings solutions solutions overview ir newsroom pr newsroom media database social media hub news center get started news center health advance inc signs letter of intent to acquire product formulations las vegas nv  newmediawire  october    health advance inc the company otc pink hadv is pleased to announce it has entered into a nonbinding letter of intent to acquire certain proprietary product formulations for the manufacturer of generic drugs from patrick ocharchin a canadian resident the acquisition is subject to due diligence by health advance and the negotiation and execution of a definitive agreement the agreement will be subject to certain conditions including the company issuing shares of the company in exchange for the formulations held by mr ocharchin the company will analyze the value of the formulations and expects the due diligence period to last approximately  weeksthe company believes the letter of intent is the next phase of its growth and development upon completion of the hantian transaction the company will utilize the strategic relationships formed by hantian to develop market and promote the formulations that will provide health advance with the greatest opportunities the formulations are currently active in the following areas i central nervous system drugs such as anticonvulsants and antipsychotics ii antiinfection drugs such as erythromycin opthalmic ointment iii topical dermatology drugs such as topical antibiotics topical antifungals and antiinflammatories iv hormonal drugs such as steroidal drugs and v other drugs such as ophthalmicsgeneric pharmaceuticals are bioequivalent same ingredients and therapeutic equivalent alternatives to brand name drugs that have lost the market exclusivity of patent protection generic drugs offer the same active chemical entity as trade name products but differ inert substance formulations inert ingredients include binders fillers artificial colors flavorings etc since these substances may affect the bioavailability performance of the active ingredient bioequivalence studies must be conducted by manufacturers and submitted to the federal food and drug administration fda before new generic products are approved for sale this file will show that the generic drug has the same ingredients in the same proportions as the brand product known as bioequivalence and performs the same as the brand product when taken known as bioavailability once this submission file is reviewed by fda and bioequivalence and bioavailability are confirmed an approval for sale is granted and the drug may be marketed all of the product formulations held by mr ocharchin have bioequivalence studies completed which will result in considerable time savings and cost savingscertain statements in this document that are not historical facts are forwardlooking statements within the meaning of the private securities litigation reform act of  such statements may be identified by the use of words such as anticipate believe expect future may will would should plan projected intend and similar expressions such forwardlooking statements involve known and unknown risks uncertainties and other factors that may cause the actual results performance or achievements of health advance inc to be materially different from those expressed or implied by such forwardlooking statements the companys future operating results are dependent upon many factors including but not limited to i the companys ability to obtain sufficient capital or a strategic business arrangement to fund its current operational or expansion plans ii the companys ability to build and maintain the management and human resources and infrastructure necessary to support the anticipated growth of its business iii competitive factors and developments beyond the companys control and iv other risk factors discussed in the companys periodic filings with the securities and exchange commission which are available for review at wwwsecgov under search for company filingscontact informationfor more information please contacthealth advance incjordan starkman ceowwwhealthadvanceinccom search home distributions distributions overview us news distributions international distribution custom industry packages targeted media  influencers photo distributions disclosureregulatory filings solutions solutions overview ir newsroom pr newsroom media database social media hub news center about us contact us get started advanced health products  home call us to place your order and for more information on becoming a distributor for our products   sign in  or  register homeabout usproductsspecialscontact us  productsdrinkcocoashakepuddingsmoothiegelatincappuccinosoupteaprotogoshaker cups advanced health products your source for highquality wholesale protein powders  for over  years advanced health products inc has supplied the weight loss community with a variety of delicious and nutritious products here you will discover  categories of protein supplements in over  flavors all formulated blended and packaged in our west chicago il fda approved facility exceeding expectations at advanced health products inc we work hard to supply our customers with an extensive variety of high quality nutritional products and weight loss products our products are available to the wholesale community with volume discounts and can be shipped anywhere in the world shipping in the usa is free at advanced health products inc you can expect to receive the best flavor profile in todays weight loss marketplace all advanced health supplements contain  grams of high quality protein and many  essential vitamins and minerals please contact us for samples and additional information resources wwwwebmdcom wwwiftorg wwweatrightorg wwwdeliciouslivingmagcom wwwwellnesslettercom wwwemedicinehealthcom site search homeabout usproductsspecialscontact us advanced health products copyright  about us  advance health products home login skip to content home about us articles contact us videos search for co enzyme q free radicals  antioxidants good health  wellbeing nutrients vitamins  minerals about us advancehealthproductscom premium q by paul o’neill is a fully australian owned and operated company advance health products aust pty ltd and operates from gisborne  victoria australia advance health products mission is to be the no  provider of the highest quality premium range of organic products relating to the most important aspects of your life your health your health and satisfaction with our website are importance to us we are constantly improving and changing our website to be the number  choice when purchasing quality premium health products an important element of that is to make information available that may help you make improvements to you and your family’s health so please visit our contact page for more information on our products and services opening hours our website is available  for your convenient so whenever you have the need to purchase  your essential premium quality health products we are open for your service payments that we accept for all customers the following credit cards visa mastercard are accepted via our eway payment platform or your paypal account if you don’t have a paypal account then it is quick and easy to setup your free account in just a few short minutes delivery for all delivery information please go to our delivery page shopping cart to add any item to your shopping cart just click on the “add to cart” button displayed below the product if you happen to change your mind as you shop you can always remove an item during the checkout process if you wish to change the quantity of any items in your shopping cart just type the new quantity in the quantity field for that product and click on “update shopping cart” button you must click the “update shopping cart” to ensure your updated quantity is saved discount structure to help our customers save on their purchases shipping and handling costs we offer a generous discount structure that saves you more the more you purchase”  see below for details  –  bottles –  discount  –  bottles –  discount  –  bottles –  discount   bottles –  discount when you have confirmed your purchase quantity you then need to obtain a quotation for the shipping charges for your purchase simply enter your country stateprovince and zippostal code as requested then click on the “get a quote” button when you receive your shipping charges quote click on the “update total” button your shopping cart is now complete when you have finished shopping and have placed all your items in your shopping cart click on “proceed to checkout” to send us your order you’ll then be prompted to enter your email and a password billing and shipping addresses and payment option we’ll receive your order immediately and will send you a confirmation email subscriptions and membership to our newsletter subscriptions are welcome to join our membership list and subscribe to our periodic newsletter currency all prices listed are in australian dollars aud when you pay by credit card the credit card company will calculate the exchange rate and include it in your monthly statement comments are closed search for recent posts herbal weight loss tea – easy slimming solution herbal weight loss remedies – options and goals learn about the three major nutrients for an effective diet weight loss plan things to remember about a fast weight loss plan weight loss plan for women recent commentsweird diet tricks that really work  anxiety tips  anxiety tips on learn about the three major nutrients for an effective diet weight loss planwhat are the different uses of advanced health products  the best carpet cleaning on coq for better immunity during travelweird diet tricks that really work  ace duck on learn about the three major nutrients for an effective diet weight loss planchaussure nike tn on videoshearty benefits of coenzyme q  scarlet vulture health  fitness on coq — the ubiquitous nutrientarchives july  june  may  april  march  february  january  november  october  september  august  july  june  may  april  march  february  january  december  november  october  september  august  july  april  categories co enzyme q free radicals  antioxidants good health  wellbeing nutrients vitamins  minerals meta log in entries rss comments rss wordpressorg premium qpromote your page too advance health products proudly powered by wimi sign up for the free ebook name email close  sign up for the free ebook sign up for the free ebook  the coenzyme q story name email health advance inc signs letter of intent to acquire product formulations questions   set up free account submit release why us press releases services pricing  comparison chart distribution resources contact contact resources contact world media directory · rss · email newsletters there were  press releases posted in the last  hours and  in the last  days health advance inc signs letter of intent to acquire product formulations einpresswirecom  las vegas nvmarketwired  oct    health advance inc the company otc pink hadv is pleased to announce it has entered into a nonbinding letter of intent to acquire certain proprietary product formulations for the manufacturer of generic drugs from patrick ocharchin a canadian resident the acquisition is subject to due diligence by health advance and the negotiation and execution of a definitive agreement the agreement will be subject to certain conditions including the company issuing shares of the company in exchange for the formulations held by mr ocharchin the company will analyze the value of the formulations and expects the due diligence period to last approximately  weeks the company believes the letter of intent is the next phase of its growth and development upon completion of the hantian transaction the company will utilize the strategic relationships formed by hantian to develop market and promote the formulations that will provide health advance with the greatest opportunities  the formulations are currently active in the following areas i central nervous system drugs such as anticonvulsants and antipsychotics ii antiinfection drugs such as erythromycin opthalmic ointment iii topical dermatology drugs such as topical antibiotics topical antifungals and antiinflammatories iv hormonal drugs such as steroidal drugs and v other drugs such as ophthalmics generic pharmaceuticals are bioequivalent same ingredients and therapeutic equivalent alternatives to brand name drugs that have lost the market exclusivity of patent protection generic drugs offer the same active chemical entity as trade name products but differ inert substance formulations inert ingredients include binders fillers artificial colors flavorings etc since these substances may affect the bioavailability performance of the active ingredient bioequivalence studies must be conducted by manufacturers and submitted to the federal food and drug administration fda before new generic products are approved for sale this file will show that the generic drug has the same ingredients in the same proportions as the brand product known as bioequivalence and performs the same as the brand product when taken known as bioavailability once this submission file is reviewed by fda and bioequivalence and bioavailability are confirmed an approval for sale is granted and the drug may be marketed all of the product formulations held by mr ocharchin have bioequivalence studies completed which will result in considerable time savings and cost savings certain statements in this document that are not historical facts are forwardlooking statements within the meaning of the private securities litigation reform act of  such statements may be identified by the use of words such as anticipate believe expect future may will would should plan projected intend and similar expressions such forwardlooking statements involve known and unknown risks uncertainties and other factors that may cause the actual results performance or achievements of health advance inc to be materially different from those expressed or implied by such forwardlooking statements the companys future operating results are dependent upon many factors including but not limited to i the companys ability to obtain sufficient capital or a strategic business arrangement to fund its current operational or expansion plans ii the companys ability to build and maintain the management and human resources and infrastructure necessary to support the anticipated growth of its business iii competitive factors and developments beyond the companys control and iv other risk factors discussed in the companys periodic filings with the securities and exchange commission which are available for review at wwwsecgov under search for company filings for more information please contact health advance inc jordan starkman ceowwwhealthadvanceinccom  share on facebook · twitter · linkedin · google distribution channels consumer goods healthcare  pharmaceuticals insurance share this story facebook twitter linkedin google print more from this source lexmark international shareholder alert by former louisiana attorney general kahn swick  foti llc reminds investors  one world minerals inc announces closing of option to acquire up to  interest in salar del diablo property dragonwave announces receipt of application to appoint receiver and tsx delisting review view all stories from this source submit release ein presswire follow einpresswire back to top quick links submit releases login set up free account pricing  comparison chart distribution resources rss email newsletters world media directory ein newsdesk newsplugin press releases all press releases featured press releases search press releases browse by date featured clients wiseguyreportscom marketwired it governance help  information center why us about ein presswire helpful tips video tutorial client testimonials blog services free press release distribution press release distribution services send press release submit free press release user agreement privacy policy contact ein news home about ein news founded in  ein news is an international leader in realtime news tracking and digital information services our systems continuously scan the web indexing news from thousands of worldwide sources the data is then filtered and organized into news streams the process is supervised by a team of professional news editors we are news professionals and technologists dedicated to producing the fastest and most comprehensive news streams on the planet we are committed to providing our members with the highest quality software tools and resources available ein news is a division of internet product development group inc to reach us send an email or call   or   ein presswire events  conferences newsfeed maker inbox robot ipd group ein twitter ein facebook   ipd group inc dba ein presswire  ein news all right reserved  user agreement  privacy policy  contact why us testimonials  client reviews blog posts video tutorials browse all releases browse featured release browse by topic browse by date free press release distribution press release distribution services send press release submit free press release press release distribution media monitoring distribution overview world media directory us tvradio microwires newsdesk newsplugin health advance inc otc pink hadv rallies  over past two trading sessions after acquiring product formulations  emerginggrowthcom home emerging growth news cannabis commodities entertainment  retail food and beverage med biotech  pharma technology video in play caveat emptor status changes search emerging growth symbol for quotes  data friday july   contact us  subscribe emerginggrowthcom home emerging growth news allcannabiscommoditiesentertainment  retailfood and beveragemed biotech  pharmatechnology emerging growth news emerginggrowthcom daily dozen – winners vs losers commodities dundee precious metals inc otc pink dpmlf rallies  after reporting… commodities liberty one lithium corp otcqb lrttf gains  after naming brad… med biotech  pharma on the move systems corp otc pink omvs dropped  after… video emerging growth news how jim cramer used the stock market to pay for harvard… technology friendable otc pink fdbl app featured in platinum recording artist daya’s… technology friendable’s otc pink fdbl app feature in fifth harmony  fetty… technology friendable’s otc pink fdbl app featured in redfoo’s virtual reality music video… video president ronald reagan speaks to the american people to announce that… in play entertainment  retail halitron inc otc pink haon broadens its target acquisitions to include… entertainment  retail flitways technology inc otc pink ftws the perfect acquisition candidate for… entertainment  retail flitways technology inc otc pink ftws  increase in sales… entertainment  retail friendable inc otc pink fdbl just got a whole lot better commodities premier holding corporation otcqb prhl board member woodrow w clark reappointed… caveat emptor status changes  or  home emerging growth news med biotech  pharma health advance inc otc pink hadv rallies  over past two trading emerging growth newsmed biotech  pharma health advance inc otc pink hadv rallies  over past two trading sessions after acquiring product formulations november   share on facebook tweet on twitter tweet health advance inc otc pink hadv is engaged in the sale and operation of a webbased medical products business shares of the health retailer are up  over the past two trading sessions including today’s rally of  through early trading on wednesday november   over the past three months health advance inc has seen average daily volume of  shares over the past three months however the company is seeing volume of nearly  shares or dollar volume of  through early trading on wednesday shares of health advance inc has been sustaining an impressive rally over the past two trading sessions after the company announced it has entered into a letter of intent for the acquisitions of “proprietary product formulations” for generic drugs the acquisition agreement is nonbinding and is said to be involving a canadian citizen patrick o’ charchin health advance inc will now conduct due diligence on the formulations over the next  weeks here is the complete press release detailing of the acquisition health advance inc press release las vegas nv–marketwired – oct   – health advance inc the “company”  otc pink  hadv  is pleased to announce it has entered into a nonbinding letter of intent to acquire certain proprietary product formulations for the manufacturer of generic drugs from patrick o’charchin a canadian resident the acquisition is subject to due diligence by health advance and the negotiation and execution of a definitive agreement the agreement will be subject to certain conditions including the company issuing shares of the company in exchange for the formulations held by mr o’charchin the company will analyze the value of the formulations and expects the due diligence period to last approximately  weeks the company believes the letter of intent is the next phase of its growth and development upon completion of the hantian transaction the company will utilize the strategic relationships formed by hantian to develop market and promote the formulations that will provide health advance with the greatest opportunities the formulations are currently active in the following areas i central nervous system drugs such as anticonvulsants and antipsychotics ii antiinfection drugs such as erythromycin opthalmic ointment iii topical dermatology drugs such as topical antibiotics topical antifungals and antiinflammatories iv hormonal drugs such as steroidal drugs and v other drugs such as ophthalmics generic pharmaceuticals are bioequivalent same ingredients and therapeutic equivalent alternatives to brand name drugs that have lost the market exclusivity of patent protection generic drugs offer the same active chemical entity as trade name products but differ inert substance formulations inert ingredients include binders fillers artificial colors flavorings etc since these substances may affect the bioavailability performance of the active ingredient bioequivalence studies must be conducted by manufacturer’s and submitted to the federal food and drug administration fda before new generic products are approved for sale this file will show that the generic drug has the same ingredients in the same proportions as the brand product known as bioequivalence and performs the same as the brand product when taken known as bioavailability once this submission file is reviewed by fda and bioequivalence and bioavailability are confirmed an approval for sale is granted and the drug may be marketed all of the product formulations held by mr o’charchin have bioequivalence studies completed which will result in considerable time savings and cost savings add a comment to this post comments related articlesmore from author emerging growth news emerginggrowthcom daily dozen – winners vs losers commodities dundee precious metals inc otc pink dpmlf rallies  after reporting second quarter  earnings commodities liberty one lithium corp otcqb lrttf gains  after naming brad nichol as new ceo stay connectedfanslikefollowersfollowfollowersfollowsubscriberssubscribe most popular emerginggrowthcom daily dozen – winners vs losers june   decision diagnostics corp otc pink decn jumps  after receiving updated july   photomedex inc otc pink phmd rallies  after k filing details july   tower one wireless corp otc pink towtf jumps  after update june   load more editor picks emerginggrowthcom daily dozen – winners vs losers july   dundee precious metals inc otc pink dpmlf rallies  after reporting july   liberty one lithium corp otcqb lrttf gains  after naming brad july   popular posts the future is approaching faster than one can handle… january   worldflix inc otc pink wrfx making children safer and smarter june   halitron inc otc pink haon a look at an equity investment may   popular categorytechnologycommoditiesmed biotech  pharmaemerging growth newscannabisentertainment  retailfood and beverageother newsin play about usemerginggrowthcom is a leading independent small cap media portal with an extensive history of providing unparalleled content for the emerging growth markets and companiescontact us infoemerginggrowthcomfollow us disclosure terms of use privacy policy contact us  subscribe  copyright   emerginggrowthcom  images via shutterstock health advance inc otcmktshadv finalizes loi to acquire product formulations  journal transcript sign in technology cannabis health care energy metals about contact us advertising disclaimer sign in welcomelog into your account your username your password forgot your password password recovery recover your password your email search sign in  join sign in welcome log into your account your username your password forgot your password get help password recovery recover your password your email a password will be emailed to you journal transcript seanergy maritime holdings corp ship on breakout alert read more technology cannabis health care energy metals about contact us advertising disclaimer loading stock data home health care health advance inc otcmktshadv finalizes loi to acquire product formulations health care health advance inc otcmktshadv finalizes loi to acquire product formulations by jason williams  november     share facebook twitter health advance inc otcmktshadv has finalized a nonbinding letter of intent to buy certain product formulations for the production of generic medications from patrick o’charchin the acquisition is contingent to comprehensive appraisal by health advance and the negotiation and implementation of a definitive deal this deal will be dependent on the closure of certain conditions including the firm issuing shares in lieu for the formulations held by o’charchin the firm will assess the formulations value and anticipates the evaluation period to last nearly  weeks the highlights health advance believes the loi is the next stage of its development and growth upon closure of the hantian deal the firm will use the strategic associations formed by hantian to advance promote and market the formulations that will offer health advance with the remarkable opportunities the formulations are presently active in the many areas central nervous system medications like antipsychotics and anticonvulsants antiinfection medications like erythromycin opthalmic ointment topical dermatology medications such as topical antiinflammatories and antifungals hormonal drugs like steroidal medications and other drugs like ophthalmics generic drugs are bioequivalent and therapeutic equivalent options to brand name medications that have lost the market uniqueness of patent protection generic medication provides the same active chemical unit as trade name items but vary inert substance formulations these include artificial colors flavorings binders fillers etc since these elements may impact the bioavailability of the active ingredient bioequivalence trials must be performed by manufacturer’s and given to the fda before new generic items are approved for sale this file will depict that the generic drug constitutes the same ingredients in the equivalent ratio as the brand product termed as bioequivalence and accomplishes the same as the trademark product when taken termed as bioavailability once this file is assessed by the fda and bioavailability and bioequivalence are established a support for sale is allowed and the medication may be commercialized all of the product preparations held by o’charchin are done with bioequivalence studies which in turn will result in considerable cost and time savings disclosure the views and opinions expressed in this article are those of the authors and do not represent the views of journaltranscriptcom readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions to read our full disclosure please go to httpswwwjournaltranscriptcomdisclaimer trending advertise herethe next big thing in biotechhttpsjournaltranscriptcomget our top rated alerts on the biotech sectorship poised to surprise investorshttpwwwsmallcapstockscomthis undervalued freight transportation company is making big movestraders need to know this nowhttpsjournaltranscriptcomwallstreet is loading up on this stock find out whyex broker makes millions on wall streethttpsjournaltranscriptcomhere is his secret to making winning trades daily get an edge over wall street leave a reply cancel reply related storiesarch therapeutics inc otcmktsarth files form qmei pharma inc nasdaqmei development of pracinostatstemcells inc nasdaqstem’s two officers and three directors resign following news of merger with greenfield farms food inc otcmktsgras files form qimmunogen inc nasdaqimgn update on trial of mirvetuximab soravtansine recent storiessteven binder appointed the new chief financial officer for mannkind corporation nasdaqmnkdjuly  xg technology inc’s nasdaqxgti vislink business acquires  million order for microwave communication devicesjuly  the community health systems nysecyh receives a blow after doctors drop their efforts of finding indiana hospital’s new ownerjuly  apple’s rival watch by fitbit inc nysefit could make a breakthrough into the market soonjuly  therapeuticsmd inc nysemkttxmd tables its crucial regulatory updates on its new drug txhrjuly  sprint corp nyses offers a huge space for job seekers as it opens new retail stores in central and north floridajuly  my size inc tlv mysz introduces a white label realsize measurement application on apple app store to enhance customer experiencejuly  jaguar animal health inc nasdaqjagx neonorm foal study could end up being put in black and white after being accepted by analecta veterinaria publishersjuly  aeterna zentaris inc nasdaqaezs delighted after fda approves its newest productjuly  a challenging time for telefonaktiebolaget lm ericsson nasdaqeric following the secondquarter lossjuly   the journal transcript is the premier online publication for news and information we provide our readers with the most comprehensive coverage on the webcontact us email protected even more news steven binder appointed the new chief financial officer for mannkind corporation health care july   xg technology inc’s nasdaqxgti vislink business acquires  million order for technology july   the community health systems nysecyh receives a blow after doctors drop health care july   popular categorybusinesstechnologysciencehealth careadvancersstockspress releases technology cannabis health care energy metals about contact us advertising disclaimer  copyright   journaltranscriptcom get our free ealerts on the market’s latest trends in cannabis energy health care metals  technology× subscribe health advance inc signs letter of intent to acquire product formulations  investing news network here debug lcxx pharmaceuticalinvesting news your trusted source for investing success pharmaceutical member login menu pharmaceutical investing health advance inc signs letter of intent to acquire product formulations « bernie sanders takes on b… do generic drugs make the… » investing news network • october   add comment health advance otcpink hadv is pleased to announce it has entered into a nonbinding letter of intent to acquire certain proprietary product formulations for the manufacturer of generic drugs from patrick o’charchin a canadian resident the acquisition is subject to due diligence by health advance and the negotiation and execution of a definitive agreement the agreement will be subject to certain conditions including the company issuing shares of the company in exchange for the formulations held by mr o’charchin the company will analyze the value of the formulations and expects the due diligence period to last approximately  weeks the company believes the letter of intent is the next phase of its growth and development upon completion of the hantian transaction the company will utilize the strategic relationships formed by hantian to develop market and promote the formulations that will provide health advance with the greatest opportunities the formulations are currently active in the following areas i central nervous system drugs such as anticonvulsants and antipsychotics ii antiinfection drugs such as erythromycin opthalmic ointment iii topical dermatology drugs such as topical antibiotics topical antifungals and antiinflammatories iv hormonal drugs such as steroidal drugs and v other drugs such as ophthalmics generic pharmaceuticals are bioequivalent same ingredients and therapeutic equivalent alternatives to brand name drugs that have lost the market exclusivity of patent protection generic drugs offer the same active chemical entity as trade name products but differ inert substance formulations inert ingredients include binders fillers artificial colors flavorings etc since these substances may affect the bioavailability performance of the active ingredient bioequivalence studies must be conducted by manufacturer’s and submitted to the federal food and drug administration fda before new generic products are approved for sale this file will show that the generic drug has the same ingredients in the same proportions as the brand product known as bioequivalence and performs the same as the brand product when taken known as bioavailability once this submission file is reviewed by fda and bioequivalence and bioavailability are confirmed an approval for sale is granted and the drug may be marketed all of the product formulations held by mr o’charchin have bioequivalence studies completed which will result in considerable time savings and cost savings certain statements in this document that are not historical facts are “forwardlooking statements” within the meaning of the private securities litigation reform act of  such statements may be identified by the use of words such as “anticipate “believe” “expect” “future” “may” “will” “would” “should” “plan” “projected” “intend” and similar expressions such forwardlooking statements involve known and unknown risks uncertainties and other factors that may cause the actual results performance or achievements of health advance inc to be materially different from those expressed or implied by such forwardlooking statements the company’s future operating results are dependent upon many factors including but not limited to i the company’s ability to obtain sufficient capital or a strategic business arrangement to fund its current operational or expansion plans ii the company’s ability to build and maintain the management and human resources and infrastructure necessary to support the anticipated growth of its business iii competitive factors and developments beyond the company’s control and iv other risk factors discussed in the company’s periodic filings with the securities and exchange commission which are available for review at wwwsecgov under “search for company filings for more information please contact health advance inc jordan starkman ceo wwwhealthadvanceinccom  get the latest pharmaceutical investing stock informationget the latest information about companies associated with pharmaceutical investing delivered directly to your inboxpharmaceuticald signaturesdelmar pharmaceuticalsq biomedrespirerx pharmaceuticalsselect all select noneby selecting company or companies above you are giving consent to receive email from those companies and remember you can unsubscribe at any time “trump’s victory could mean the end of obamacare is right now a good time to invest in pharmaceutical stocks” learn everything an investor needs to know about investing in pharmaceuticals get my free report click here to download for free return to the company news index article meta data « bernie sanders takes on b… do generic drugs make the… » related postsstart here  investing in pharmabiocorrx will offer recovery program for opioid abuse in ohiohow to invest in cardiovascular disease treatments top nasdaq biotech stocks novavax leads the weekpharmaceutical pet market could reach  billion by tags acquisition ceo dermatology drugs fda food and drug administration generic generic drugs health inc opthalmic patent patent protection pharmaceuticals resources sec shares zinc supply comments leave a reply click here to cancel reply name required email will not be published required comment markets top resource news robert friedland copper will con  views major miner rio tinto signs mou t  views  top mining execs share secrets  views jim rickards thoughts on the us  views video — traveling to fission uran  views byron king all things favor gold  views top technology news fandom sports ceo henri holm  views how to invest in robotics  views infographic all things you need  views cryptocurrencies still on the ris  views dynacert ceo jim payne  views netapp announces collaboration wi  views top life science news  top nasdaq biotech stocks nova  views  small medical device companies  views  antiaging stocks  views aralez pharmaceuticals to report  views how to invest in cardiovascular d  views atossa genetics completes enrollm  views most popular stocks westhaven ventures inc  views friday night inc  views naturally splendid enterprises  views angkor gold  views nemaska lithium  views lexaria bioscience  views tweets by innlifescience download free reports resource investing investing in medical cannabis and legal cannabis stocks in gold trends and gold outlook  key highlights for investorssilver price forecast  and silver stocks to buyprecious metals outlook  ceo’s analysts on gold silver and platinumuranium price forecasts  and top uranium stocks to watchresource forecast  – expert opinions covering precious metals energy critical metals and moreindustrial metals outlook and stocks to watchcopper market outlook and copper companies lithium forecast  and lithium stocks to buycobalt  market forecast and cobalt stocks to buygraphite investing outlook  and graphite stocks to buyzinc market outlook  and best of zinc stockscritical metals price forecast  and stocks to watchagriculture investing in  market forecast for phosphate potash and morerare earth expert interviews and rare earth stocks to buybase metals prices  and investing opportunitiesenergy investing outlook  and energy stocks to watchinvesting in diamond stocks diamond juniors colored diamonds and moreplatinum industry insights and top stocks to buytungsten price tungsten demand and tungsten stockscoal prices and market forecastoil prices market forecasts and top investment optionsthe top palladium etfs bullions and stocks to buystart here – investing in cannabisstart here – investing in goldstart here – investing in silverstart here – investing in lithiumstart here – investing in oil and gasstart here – investing in uraniumstart here – investing in resourcesstart here – investing in precious metalsstart here – investing in critical metalsstart here – investing in copperstart here – investing in graphitestart here – investing in energystart here – investing in cobaltstart here – investing in base metalsstart here – investing in leadstart here – investing in potashgold trends  and gold outlook  key highlights for investorsgold trends and gold outlook  key highlights for investorspotash market report prices production and trends life science investing pharmaceutical investing principles and pharmaceutical stocks to buy life science and healthcare investing in medical device market forecast  and stocks to buygenetics market outlook  latest in genetic research trends and top stocks to buybiotech investing in  – top biotech stocks etfs and future prospectsstart here – investing in medical devicesstart here – investing in life sciencestart here – investing in geneticsstart here – investing in biotechstart here – investing in pharma tech investing fintech investing and rising fintech companies to watch in tech forecast and promising tech stocks to buy in cloud computing market report and market forecast cleantech market trends in  and cleantech stocks to buyunderstanding bitcoins from bitcoin mining to the bitcoin ratenanotech forecast  the next great wave of nanotech stocks to buygraphene trends stocks and market forecast what the pros think and where the market is headedd printing market outlook and d printing stocks to buystart here – investing in fintechstart here – investing in d printingstart here – investing in cleantechstart here – data investing factsstart here – investing in cybersecuritystart here – investing in mobile webstart here – investing in tech browse topics resource investing agriculture investing cannabis investing phosphate investing potash investing base metals investing copper investing iron investing lead investing nickel investing zinc investing critical metals investing cobalt investing graphite investing magnesium investing manganese investing rare earth investing scandium investing tantalum investing tellurium investing tungsten investing energy investing gas investing lithium investing oil and gas investing oil investing uranium investing gem investing diamond investing industrial metals investing aluminum investing chromium investing coal investing molybdenum investing tin investing vanadium investing precious metals investing gold investing palladium investing platinum investing silver investing tech investing d printing investing app investing cleantech investing cloud investing cybersecurity investing data investing fintech investing graphene investing mobile web investing nanotech investing life science investing biotech investing genetics investing longevity investing medical device investing pharmaceutical investing featured stocks d signatures genomic imaging for precision medicinerespirerx pharmaceuticalsq biomeddelmar pharmaceuticalsview all featured stocks   enter your log in credentials email password remember me create new password no password sign up × privacy  legal policy privacy policy × investing news network health advance inc signs letter of intent to acquire product formulationshomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets closedsp  dow  nasdaq listenwho is the face of pro baseballyahoo finances dan roberts and myles udland debate the business of baseballhealth advance inc signs letter of intent to acquire product formulationsmarketwiredoctober  reblogsharetweetsharelas vegas nvmarketwired  oct    health advance inc the company  otc pink  hadv  is pleased to announce it has entered into a nonbinding letter of intent to acquire certain proprietary product formulations for the manufacturer of generic drugs from patrick ocharchin a canadian resident the acquisition is subject to due diligence by health advance and the negotiation and execution of a definitive agreement the agreement will be subject to certain conditions including the company issuing shares of the company in exchange for the formulations held by mr ocharchin the company will analyze the value of the formulations and expects the due diligence period to last approximately  weeksthe company believes the letter of intent is the next phase of its growth and development upon completion of the hantian transaction the company will utilize the strategic relationships formed by hantian to develop market and promote the formulations that will provide health advance with the greatest opportunities the formulations are currently active in the following areas i central nervous system drugs such as anticonvulsants and antipsychotics ii antiinfection drugs such as erythromycin opthalmic ointment iii topical dermatology drugs such as topical antibiotics topical antifungals and antiinflammatories iv hormonal drugs such as steroidal drugs and v other drugs such as ophthalmicsgeneric pharmaceuticals are bioequivalent same ingredients and therapeutic equivalent alternatives to brand name drugs that have lost the market exclusivity of patent protection generic drugs offer the same active chemical entity as trade name products but differ inert substance formulations inert ingredients include binders fillers artificial colors flavorings etc since these substances may affect the bioavailability performance of the active ingredient bioequivalence studies must be conducted by manufacturers and submitted to the federal food and drug administration fda before new generic products are approved for sale this file will show that the generic drug has the same ingredients in the same proportions as the brand product known as bioequivalence and performs the same as the brand product when taken known as bioavailability once this submission file is reviewed by fda and bioequivalence and bioavailability are confirmed an approval for sale is granted and the drug may be marketed all of the product formulations held by mr ocharchin have bioequivalence studies completed which will result in considerable time savings and cost savingscertain statements in this document that are not historical facts are forwardlooking statements within the meaning of the private securities litigation reform act of  such statements may be identified by the use of words such as anticipate believe expect future may will would should plan projected intend and similar expressions such forwardlooking statements involve known and unknown risks uncertainties and other factors that may cause the actual results performance or achievements of health advance inc to be materially different from those expressed or implied by such forwardlooking statements the companys future operating results are dependent upon many factors including but not limited to i the companys ability to obtain sufficient capital or a strategic business arrangement to fund its current operational or expansion plans ii the companys ability to build and maintain the management and human resources and infrastructure necessary to support the anticipated growth of its business iii competitive factors and developments beyond the companys control and iv other risk factors discussed in the companys periodic filings with the securities and exchange commission which are available for review at wwwsecgov under search for company filingsreblogsharetweetsharerecently viewedyour list is emptywhat to read nextab inbev bud earnings and revenues miss estimates in qzacksengineer finds pattern makes millions in stocksmoney morningsponsoredjeff bezos’ brief stint as world’s richest human ends with amazon’s secondquarter whifftechcrunchwill phillips  psx disappoint this earnings seasonzacksunder armour uaa to report q earnings what lies aheadzacksthis will be in everyones household by banyan hillsponsoredcan bp plc bp spring a surprise this earnings seasonzacksthe two pizza rule is a secret to productive meetings that helped amazon ceo jeff bezos become one of the worlds richest menbusiness insiderhere are the us targets north korea most likely wants to nukebusiness insider mustown stocks in banyan hillsponsoredapnewsbreak yellowstone park cracks down on sex harassmentassociated presschevron and exxon mobil have a tough path ahead nyse traderyahoo finance videostocks mixed after heavy earnings weekthe travel card that is breaking thwise breadsponsoredtrump to cops please dont be too nice while arresting thugs and dont worry about their heads when you toss them in the paddy wagonbusiness insiderthe real reason overseas manufacturing is coming to americayahoo financetrump replaces chief of staff reince priebus with homeland security chief john kellydanielle this presidency is out of control muellerplease bring this travesty to a stop soonjoin the conversation  k